09 Jun

Top US Panel: Some Vaccine-Autism Research is “Appropriate,” “Worthwhile” and “Warranted”

The endorsement, from the highly influential National Vaccine Advisory Committee, will surely intensify the argument.

By David Kirby

Full Article under Pages titled “Autism”

On Tuesday, the Federal Government’s leading immunization advisory panel unanimously approved a sweeping list of vaccine safety research recommendations for the US Department of Health and Human Services, including several that are directly or indirectly linked to the vaccine-autism debate. The endorsement, from the highly influential National Vaccine Advisory Committee, will surely intensify the argument.

Proponents of continued research into possible relationships between vaccination and a wide variety of immunological, metabolic and neurodevelopmental disorders will be cheered by many of the recommendations, while their critics will take comfort in noting that the NVAC declared that the epidemiological evidence to date assured them there is no link between vaccines and autism, at least within “the general population.”

Still, major gaps in research plague our complete understanding of vaccine safety, the committee seemed to be saying. We don’t really know how our current immunization schedule might affect certain susceptible populations that might be at greater risk for vaccine injury. It is plausible that some children — for a variety of reasons — cannot handle the one-size-fits-all vaccine schedule and its many ingredients. Those subgroups should be separated out and studied on their own, the NVAC said.

Despite its rejection of vaccines as a general cause of autism, the panel nonetheless backed two vaccine-autism related measures — plus a lengthy list of study ideas that mirror what autism and vaccine-safety advocates have been requesting for years. Many of those advocates had direct input into the formulation of the groundbreaking document……………………………………………………………….

Comment from a mother of autistic children:

Wow, this is indeed good news! Astonishing movement towards re-evaluating the exisiting “science” and broading the anaylsis of vaccine impact on several fronts.

It’s great that they are considering using the Omnibus cases as part of the analysis:

“The obvious place to do these analyzes, it seems to me, is the Omnibus Autism Proceedings in vaccine court, where some 5,000 regressive cases are pending. And, more than 1,300 vaccine court cases were already paid out for encephalopathy and seizure disorders. We will soon learn how many of those children also have an ASD, though I can confirm now that it appears to be far, far higher than the1-in-150 rate reported by CDC.”

I wonder if and how this may impact the pending Omnibus cases that are primarily thimerosal causation?

The Michigan Austim-Insurance bill is in hearings this week and next week (tuesday).

Comments are closed.

© 2021 | Entries (RSS) and Comments (RSS)

Global Positioning System Gazettewordpress logo